CD19 Fc-Fusion Protein for Detection of Cells Expressing Anti-CD19 Chimeric Antigen Receptors

被引：0
|
作者：
De Oliveira, Satiro N. [1 ]
Wang, Jiexin [1 ]
Hollis, Roger P. [1 ]
Kohn, Donald B. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1539 / 1539
页数：1
相关论文
共 50 条
  • [21] Expression of CD19 Antigen on Chronic Lymphocytic Leukemia Cells after Tafasitamab (Anti-CD19) Treatment: Phase I Trial Data
    Boxhammer, Rainer
    Striebel, Frank
    Baumgartner, Roland
    Endell, Jan
    BLOOD, 2019, 134
  • [22] Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
    Qin, Haiying
    Ramakrishna, Sneha
    Nguyen, Sang
    Fountaine, Thomas J.
    Ponduri, Anusha
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    Haso, Waleed
    Shern, Jack F.
    Shah, Nirali N.
    Fry, Terry J.
    MOLECULAR THERAPY-ONCOLYTICS, 2018, 11 : 127 - 137
  • [23] Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor (CAR) T cells
    Alnabhan, Rehab
    Magalhaes, Isabelle
    Mattson, Jonas
    Uhlin, Michael
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 332 - 332
  • [24] A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy
    Liu Meijing
    Cui, Rui
    Mu, Juan
    Yuan, Ji-Jun
    Mou, Nan
    Yang, Zhen-xing
    Jiang Yan-yu
    Meng Juanxia
    Deng, Qi
    BLOOD, 2019, 134
  • [25] The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies
    Cao, Jun-Xia
    Gao, Wei-Jian
    You, Jia
    Wu, Li-Hua
    Liu, Jin-Long
    Wang, Zheng-Xu
    CYTOTHERAPY, 2019, 21 (07) : 769 - 781
  • [26] Development of Anti-CD19 Chimeric Antigen Receptor T-Cells with Immune Checkpoint Silencing
    Matthes, Thomas
    Roussel-Gervais, Audrey
    Salmon, Patrick
    Ilmjarv, Sten
    Sakic, Antonija
    Krause, Karl-Heinz
    Alessandrini, Marco
    MOLECULAR THERAPY, 2021, 29 (04) : 312 - 312
  • [27] Development and in vivo evaluation of anti-CD19 chimeric antigen receptor (CAR) -yδt cells
    Kim, Nayoung
    Kim, Hyery
    Im, Ho Joon
    Koh, Kyung-Nam
    TISSUE ENGINEERING PART A, 2022, 28 : 278 - 278
  • [28] T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells (vol 4, pg 498, 2016)
    Zah, Eugenia
    Lin, Meng-Yin
    Silva-Benedict, Anne
    Jensen, Michael C.
    Chen, Yvonne Y.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (07) : 639 - 641
  • [29] Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells
    Mirzaei, Hamid Reza
    Jamali, Arezoo
    Jafarzadeh, Leila
    Masoumi, Elham
    Alishah, Khadijeh
    Mehrjardi, Keyvan Fallah
    Emami, Seyed Amir Hossein
    Noorbakhsh, Farshid
    Till, Brian G.
    Hadjati, Jamshid
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 9207 - 9215
  • [30] A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells
    Ruella, Marco
    Barrett, David M.
    Shestova, Olga
    Perazzelli, Jessica
    Posey, Avery D., Jr.
    Hong, Seok Jae
    Kozlowski, Miroslaw
    Lacey, Simon F.
    Melenhorst, J. Joseph
    June, Carl H.
    Gill, Saar, I
    BLOOD, 2020, 135 (07) : 505 - 509
12345